The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Turkey’s health insurance coverage reaches 98.4% of the population, according to the OECD Health Statistics 2017. The state, through the Ministry of Health (MoH), is the main provider of health services in the country, which still has very low ...READ MORE
In 2012-2017 Chile’s total health expenditure rose at a CAGR of 11.6%, driven by a solid increase of government spending on healthcare. In 2017, Chile allocated 8.1% of its GDP on healthcare, a figure that is bound to grow in the short term. ...READ MORE
Poland is the sixth-largest market in Europe (understood as EU28 plus Norway and Switzerland) for pharmaceuticals as well as for cosmetics, with respective market sales of around PLN 38.3bn in 2017 and of at least PLN 16bn in 2016 (some estimates, ...READ MORE
Expenditure on healthcare in Romania reached RON 35.2bn in 2015, according to data provided by Eurostat. Total expenditure on healthcare was equal to 4.94% of GDP in that year. The Romanian healthcare sector was characterised by the lowest per capita ...READ MORE
Total expenditure on healthcare in Hungary in 2015 reached HUF 2,460bn, up by 6.3% y/y. Government and compulsory health care financing schemes made up 67% of the expenditure, followed by private out-of-pocket spending (29%). Voluntary healthcare ...READ MORE
The chemical manufacturing sector is among the fastest growing segments of the Chinese industry. Over the past ten years, the gross value added (GVA) of the sector has been increasing by 12.7% per year on average, far above the overall ...READ MORE
With estimated net revenues of USD 119.6bn in 2017, Brazil’s chemical sector was the eighth largest in the world and the leader in Latin America. Compared to 2016, the industry’s turnover rose by 9.5% y/y, as the uptick in ...READ MORE
In 2016 Poland’s healthcare expenditure grew by 4.5% y/y to PLN 119.27bn, representing 6.4% of the GDP. Public healthcare spending in Poland is one of the lowest compared to the EU average, which hovers around 6.5 % of GDP. The bulk of the ...READ MORE
India has one of the largest chemical sectors in the world by production volumes, and growth is expected to accelerate given the country’s increasing development. The chemicals sector plays an important role in the Indian economy, ...READ MORE
Russia’s healthcare and pharmaceutical sector was badly affected by the 2015-2016 recession, which resulted in a sharp drop in government spending, while the weak rouble and high inflation cut into households’ disposable incomes. Though ...READ MORE